Octride 0.05mg Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Octreotide acetate (0.05mg)
Overview Octride 0.05mg Injection
Octreotide 0.05mg injection treats acromegaly, carcinoid tumors, and gastrointestinal bleeding from esophageal varices. It also helps prevent post-pancreatic surgery complications. Administration is exclusively by a healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined solely by your physician. Consistent use maximizes therapeutic efficacy; discontinue only upon explicit medical instruction. Common side effects include diarrhea, abdominal discomfort, nausea, constipation, flatulence, and headache. Report persistent or worsening side effects to your doctor. Prior to treatment, disclose any liver conditions and a complete list of current medications.
Primary Ingredients of Octride 0.05mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Octride 0.05mg Injection
Overgrowth of the extremities, carcinoid cancers, and esophageal variceal hemorrhage.
Major Benefits of Octride 0.05mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Octride 0.05mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Octride 0.05mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
How Octride 0.05mg Injection works:
Octreotide 0.05 mg injection mimics the action of somatostatin, a naturally occurring human hormone regulator. This medication suppresses the activity of several hormones, including growth hormone, and reduces esophageal bleeding through vasoconstriction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Octride 0.05mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable form of octreotide (0.05mg) is typically regarded as safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; yet, data from human studies remains scarce.
Breast feedingSAFE IF PRESCRIBED
Sandostatin LAR Depot 0.05mg injection is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingSAFE
Administering Octride 0.05mg Injection typically has no impact on driving capabilities.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Octride 0.05mg Injection without requiring a dosage modification.
LiverCAUTION
For individuals with hepatic impairment, administering Octride 0.05mg Injection requires careful consideration. Dosage modification of Octride 0.05mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Octride 0.05mg Injection :
Should you forget a dose of Octride 0.05mg Injection, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Octride 0.05mg Injection
| Label | Value |
|---|---|
| Chemical Category | Somatostatin analogs |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
| Actions | Somatostatin analogs |
3,018 People bought this recently